Identification | Back Directory | [Name]
PF-02575799 | [CAS]
863491-70-7 | [Synonyms]
PF-02575799 PF02575799,PF 02575799 6-Quinolinecarboxamide, N-[(1S)-2-[[(4-fluorophenyl)methyl]methylamino]-2-oxo-1-phenylethyl]-2-[[[4'-(1-methylethoxy)[1,1'-biphenyl]-2-yl]carbonyl]amino]- | [Molecular Formula]
C42H37FN4O4 | [MDL Number]
MFCD30533363 | [MOL File]
863491-70-7.mol | [Molecular Weight]
680.78 |
Chemical Properties | Back Directory | [Boiling point ]
854.9±65.0 °C(Predicted) | [density ]
1.263±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
10.63±0.43(Predicted) |
Hazard Information | Back Directory | [Uses]
PF-02575799, is a microsomal triglyceride transfer protein (MTP) inhibitor with an IC50 of 0.77±0.29 nM. | [in vivo]
PF-02575799 produces appreciable triglyceride effects at its minimally effective dose (10 mg/kg). PF-02575799 significant increase alanine transaminase at 100 mg/kg[1]. |
|
Company Name: |
cjbscvictory
|
Tel: |
13348960310 |
Website: |
https://www.weikeqi-biotech.com/ |
|